Human gene therapy - JoVE Visualize

Showing results (481-490 of 4,122) with videos related to

Pageof 413

Sort By:

Human Gene Therapy|July 8, 1999

Gene therapy for canine alpha-L-iduronidase deficiency: in utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of diseaseC Lutzko, F Omori, A C Abrams-Ogg, et al.

Human Gene Therapy|May 26, 1999

Antiangiogenic gene therapy in a rat glioma model using a dominant-negative vascular endothelial growth factor receptor 2M R Machein, W Risau, K H Plate

Human Gene Therapy|May 26, 1999

Feasibility of adenovirus-mediated nonsurgical synovectomy in collagen-induced arthritis-affected rhesus monkeysP H Goossens, G J Schouten, B A 't Hart, et al.

Human Gene Therapy|May 26, 1999

Retrovirus-mediated transfer of anti-MDR1 ribozymes fully restores chemosensitivity of P-glycoprotein-expressing human lymphoma cellsF S Wang, H Kobayashi, K W Liang, et al.

Human Gene Therapy|May 26, 1999

In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trialJ R Herman, H L Adler, E Aguilar-Cordova, et al.

Human Gene Therapy|February 27, 1999

Persistence of an [E1-, polymerase-] adenovirus vector despite transduction of a neoantigen into immune-competent miceH Hu, D Serra, A Amalfitano

Human Gene Therapy|February 27, 1999

Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunityM Toda, S D Rabkin, H Kojima, et al.

Human Gene Therapy|February 27, 1999

Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapyM Lanuti, G P Gao, S D Force, et al.

Human Gene Therapy|March 27, 1999

Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusionC A Benedict, R Y Tun, D B Rubinstein, et al.

Human Gene Therapy|March 27, 1999

Efficient discrimination between different densities of target antigen by tetracycline-regulatable T bodiesL Alvarez-Vallina, S J Russell

Pageof 413

Showing results (481-490 of 4,122) with videos related to

Sort By:

Pageof 413

Human Gene Therapy|July 8, 1999

Gene therapy for canine alpha-L-iduronidase deficiency: in utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of diseaseC Lutzko, F Omori, A C Abrams-Ogg, et al.

Human Gene Therapy|May 26, 1999

Antiangiogenic gene therapy in a rat glioma model using a dominant-negative vascular endothelial growth factor receptor 2M R Machein, W Risau, K H Plate

Human Gene Therapy|May 26, 1999

Feasibility of adenovirus-mediated nonsurgical synovectomy in collagen-induced arthritis-affected rhesus monkeysP H Goossens, G J Schouten, B A 't Hart, et al.

Human Gene Therapy|May 26, 1999

Retrovirus-mediated transfer of anti-MDR1 ribozymes fully restores chemosensitivity of P-glycoprotein-expressing human lymphoma cellsF S Wang, H Kobayashi, K W Liang, et al.

Human Gene Therapy|May 26, 1999

In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trialJ R Herman, H L Adler, E Aguilar-Cordova, et al.

Human Gene Therapy|February 27, 1999

Persistence of an [E1-, polymerase-] adenovirus vector despite transduction of a neoantigen into immune-competent miceH Hu, D Serra, A Amalfitano

Human Gene Therapy|February 27, 1999

Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunityM Toda, S D Rabkin, H Kojima, et al.

Human Gene Therapy|February 27, 1999

Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapyM Lanuti, G P Gao, S D Force, et al.

Human Gene Therapy|March 27, 1999

Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusionC A Benedict, R Y Tun, D B Rubinstein, et al.

Human Gene Therapy|March 27, 1999

Efficient discrimination between different densities of target antigen by tetracycline-regulatable T bodiesL Alvarez-Vallina, S J Russell

Pageof 413